戻る Agendas
HOW TO OVERCOME CHALLENGES IN THE DEVELOPMENT OF MEDICINES TO TREAT DEMENTIA
Session Chair(s)
Karl Broich, DrMed
President
Federal Institute for Drugs and Medical Devices (BfArM), Germany
In this session you will be updated about the EU regulatory position on the development of drugs in dementia including the qualification procedure concerning novel methodologies, the current discussion paper and stake holder collaboration.
Speaker(s)
How to Find the Right Patients: New diagnostic criteria for AD
Bruno Dubois
Hopital de la Salpetriere, France
Department of Neurologie
Qualification Procedure: Fostering new approaches using the example of AD
Maria Begona Isaac, MD, PHD, MS, MSC
European Medicines Agency, Netherlands
Senior Scientific Officer, Product Development Scientific Support Department
IMI PharmaCog and Beyond: benefits and perspectives
Olivier Blin
Marseille University Hospital, France
Industry’ s Learning Curve - answering to challenges
Luc Truyen, MD, PHD
Johnson & Johnson Prd., United States
Vice President, Clinical Research & Development